(Post-pandemic Era)-Global Acne Vulgaris Treatment Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2438067
- Published On: Apr, 2021
- Category : Medical Devices
- Pages : 110
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Acne Vulgaris Treatment market in this environment.
In terms of revenue, this research report indicated that the global Acne Vulgaris Treatment market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Acne Vulgaris Treatment industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Common Pharma Inc aims at producing XX K Units Acne Vulgaris Treatment in 2020, with XX % production to take place in global market, Cutanea Life Sciences Inc accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Acne Vulgaris Treatment Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Acne Vulgaris Treatment Market
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Major Type of Acne Vulgaris Treatment Covered in Research report:
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Application Segments Covered in Research Market
Clinic
Hospital
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Acne Vulgaris Treatment market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Acne Vulgaris Treatment Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 CB-0601 -Product Introduction and Major Manufacturers
1.1.2 CJM-112 -Product Introduction and Major Manufacturers
1.1.3 CLS-007 -Product Introduction and Major Manufacturers
1.1.4 Dapsone -Product Introduction and Major Manufacturers
1.1.5 DFD-10 -Product Introduction and Major Manufacturers
1.1.6 DLX-2323 -Product Introduction and Major Manufacturers
1.1.7 Others -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Acne Vulgaris Treatment Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Acne Vulgaris Treatment Market
3.1.1 Top Companies leading Acne Vulgaris Treatment Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Acne Vulgaris Treatment Market
3.2.1 Top Companies leading Acne Vulgaris Treatment Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Acne Vulgaris Treatment Market
3.3.1 Top Companies leading Acne Vulgaris Treatment Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Acne Vulgaris Treatment Market
3.4.1 Top Companies leading Acne Vulgaris Treatment Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Acne Vulgaris Treatment Market
3.5.1 Top Companies leading Acne Vulgaris Treatment Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Acne Vulgaris Treatment Market
3.6.1 Top Companies leading Acne Vulgaris Treatment Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Acne Vulgaris Treatment Market
3.7.1 Top Companies leading Acne Vulgaris Treatment Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Acne Vulgaris Treatment Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Acne Vulgaris Treatment Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Acne Vulgaris Treatment Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Acne Vulgaris Treatment Sales and Growth Rate (2021-2027)
5.2 Global Acne Vulgaris Treatment Sales Value and Growth Rate (2021-2027)
6 Acne Vulgaris Treatment Competitive Analysis6.1 Common Pharma Inc
6.1.1 Common Pharma Inc Company Profiles
6.1.2 Common Pharma Inc Product Introduction
6.1.3 Common Pharma Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 Cutanea Life Sciences Inc
6.2.1 Cutanea Life Sciences Inc Company Profiles
6.2.2 Cutanea Life Sciences Inc Product Introduction
6.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 Dermira Inc
6.3.1 Dermira Inc Company Profiles
6.3.2 Dermira Inc Product Introduction
6.3.3 Dermira Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 ELORAC Inc
6.4.1 ELORAC Inc Company Profiles
6.4.2 ELORAC Inc Product Introduction
6.4.3 ELORAC Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 Ensol Biosciences Inc
6.5.1 Ensol Biosciences Inc Company Profiles
6.5.2 Ensol Biosciences Inc Product Introduction
6.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.5.4 SWOT Analysis6.6 Foamix Pharmaceuticals Ltd
6.6.1 Foamix Pharmaceuticals Ltd Company Profiles
6.6.2 Foamix Pharmaceuticals Ltd Product Introduction
6.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Galderma SA
6.7.1 Galderma SA Company Profiles
6.7.2 Galderma SA Product Introduction
6.7.3 Galderma SA Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 GlaxoSmithKline Plc
6.8.1 GlaxoSmithKline Plc Company Profiles
6.8.2 GlaxoSmithKline Plc Product Introduction
6.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Helix BioMedix Inc
6.9.1 Helix BioMedix Inc Company Profiles
6.9.2 Helix BioMedix Inc Product Introduction
6.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.9.4 SWOT Analysis6.10 Hovione FarmaCiencia SA
6.10.1 Hovione FarmaCiencia SA Company Profiles
6.10.2 Hovione FarmaCiencia SA Product Introduction
6.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Lee's Pharmaceutical Holdings Ltd
6.12 LEO Pharma A/S
6.13 Novabiotics Ltd
6.14 Novan Inc
6.15 Novartis AG
6.16 Paratek Pharmaceuticals Inc
6.17 Pfizer Inc
6.18 Phosphagenics Ltd
7 Conclusion
-
The (Post pandemic Era) Global Acne Vulgaris Treatment Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Acne Vulgaris Treatment Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the (Post pandemic Era) Global Acne Vulgaris Treatment Market has been segmented into
In 2023, the (Post pandemic Era) Global Acne Vulgaris Treatment Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the (Post pandemic Era) Global Acne Vulgaris Treatment Market as well as its distribution among its players
The (Post pandemic Era) Global Acne Vulgaris Treatment Market is expected to reach a considerable market valuation.
